Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese Encephalitis
- 1 May 1999
- Vol. 257 (2), 363-372
- https://doi.org/10.1006/viro.1999.9695
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Yellow Fever VaccinesBiologicals, 1997
- Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in miceVaccine, 1997
- Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control studyThe Lancet, 1996
- Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213Virus Research, 1995
- Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in miceJournal of General Virology, 1991
- Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation processVirus Genes, 1991
- Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccinesNucleic Acids Research, 1989
- Protection against Japanese Encephalitis by Inactivated VaccinesNew England Journal of Medicine, 1988
- Selection of Attenuated Dengue 4 Viruses by Serial Passage in Primary Kidney CellsThe American Journal of Tropical Medicine and Hygiene, 1984
- The In Vivo Differentiation of Strains of Yellow Fever Virus in MiceJournal of General Virology, 1980